FibroGen, Inc

Historical 13F Holders

Symbol
FGEN
CUSIP
31572Q808
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 61 33.0 M $10.2 M
2024 Q4 77 37.3 M $19.7 M
2024 Q3 79 47.6 M $19.5 M
2024 Q2 115 57.1 M $50.9 M
2024 Q1 122 62.2 M $147 M
2023 Q4 111 71.2 M $63.1 M
2023 Q3 122 68.4 M $59.0 M
2023 Q2 195 76.4 M $208 M
2023 Q1 190 76.4 M $1.43 B
2022 Q4 161 79.2 M $1.27 B
2022 Q3 166 73.3 M $954 M
2022 Q2 163 70.9 M $749 M
2022 Q1 172 68.0 M $817 M
2021 Q4 182 66.8 M $942 M
2021 Q3 179 64.1 M $657 M
2021 Q2 207 67.7 M $1.80 B
2021 Q1 212 71.2 M $2.47 B
2020 Q4 242 72.6 M $2.69 B
2020 Q3 232 68.9 M $2.84 B
2020 Q2 214 67.4 M $2.73 B
2020 Q1 211 64.8 M $2.25 B
2019 Q4 235 62.5 M $2.68 B
2019 Q3 228 60.9 M $2.25 B
2019 Q2 216 61.8 M $2.79 B
2019 Q1 245 58.1 M $3.16 B
2018 Q4 221 57.7 M $2.67 B
2018 Q3 206 57.8 M $3.51 B
2018 Q2 205 65.1 M $4.07 B
2018 Q1 208 54.1 M $2.50 B
2017 Q4 203 50.9 M $2.67 B
2017 Q3 196 48.2 M $2.59 B
2017 Q2 160 37.9 M $1.23 B
2017 Q1 154 31.2 M $771 M
2016 Q4 149 31.1 M $667 M
2016 Q3 142 30.8 M $637 M
2016 Q2 151 31.7 M $519 M
2016 Q1 145 32.9 M $699 M
2015 Q4 146 31.9 M $974 M
2015 Q3 123 30.2 M $679 M
2015 Q2 98 25.2 M $592 M
2015 Q1 76 16.1 M $500 M
2014 Q4 66 15.8 M $426 M